Search research articles
Contact Us
Filters
Showing results (61-70 of 117) with videos related to
Page
of 12
Sort By:
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1990
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease
A Bosly, P Brice, Y Humblet, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2004
Acute renal failure as the first presenting sign of non-Hodgkin's lymphoma
B Krug, B Willemart, I Mathieu, et al.
Acta Clinica Belgica
|
October 7, 2004
Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac disease
A Sonet, I Théate, M Delos, et al.
British Journal of Haematology
|
September 21, 2000
A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells
C Jacquy, A Sorée, F Lambert, et al.
Leukemia
|
July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)
A Delannoy, P Martiat, J L Gala, et al.
Leukemia & Lymphoma
|
May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndrome
M Maerevoet, E Van Den Neste, A Delannoy, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group
Y Humblet, P Weynants, A Bosly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)
E Lepage, C Gisselbrecht, C Haioun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen
A Bosly, B Coiffier, C Gisselbrecht, et al.
Acta Clinica Belgica
|
April 25, 2007
Guidelines for the transfusion of platelets
A Bosly, L Muylle, L Noens, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 117) with videos related to
Sort By:
Page
of 12
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1990
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease
A Bosly, P Brice, Y Humblet, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2004
Acute renal failure as the first presenting sign of non-Hodgkin's lymphoma
B Krug, B Willemart, I Mathieu, et al.
Acta Clinica Belgica
|
October 7, 2004
Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac disease
A Sonet, I Théate, M Delos, et al.
British Journal of Haematology
|
September 21, 2000
A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells
C Jacquy, A Sorée, F Lambert, et al.
Leukemia
|
July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)
A Delannoy, P Martiat, J L Gala, et al.
Leukemia & Lymphoma
|
May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndrome
M Maerevoet, E Van Den Neste, A Delannoy, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1989
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group
Y Humblet, P Weynants, A Bosly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1993
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte)
E Lepage, C Gisselbrecht, C Haioun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1992
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen
A Bosly, B Coiffier, C Gisselbrecht, et al.
Acta Clinica Belgica
|
April 25, 2007
Guidelines for the transfusion of platelets
A Bosly, L Muylle, L Noens, et al.
Page
of 12